期刊文献+

白念珠菌氟康唑耐药机制的研究进展 被引量:6

Mechanisms of fluconazole-resistant in Candida albicans
下载PDF
导出
摘要 白念珠菌作为现代医学最重要的机会性致病酵母菌,严重威胁患者的生命。氟康唑为临床治疗念珠菌感染的首选药物,其广泛使用,使得念珠菌耐药日益增加。本文综述白念珠菌氟康唑耐药机制的研究进展。 As the most important opportunistic pathogenic yeast in modem medicine, Candida albicans threat seriously to the lives of patients. Fluconazole, as the drag of first choice, has been used widely in the treatment of Candida infections. It could increase the chance of the antifungal resistance in Candida albieans. This article focused on the progress of flueonazole-resistant mechanisms.
作者 索桂英 付萍
出处 《皮肤病与性病》 2013年第2期90-91,94,共3页 Dermatology and Venereology
关键词 白念珠菌 氟康唑 耐药机制 Candida albicans Flueonazole Drug resistance mechanism
  • 相关文献

参考文献6

二级参考文献65

  • 1乔建军,刘伟,李若瑜.白念珠菌耐药的分子机制研究进展[J].微生物学通报,2007,34(2):393-396. 被引量:9
  • 2苏英,李春阳.敏感和耐药白念珠菌磷脂酶活力与其毒力关系的研究[J].山东大学学报(医学版),2007,45(5):535-537. 被引量:4
  • 3刘伟,李若瑜.几种新型抗真菌药物简介[J].微生物学通报,2007,34(3):617-620. 被引量:6
  • 4National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. M27-A2 [ M]. National Committee for Clinical Laboratory Standards, WAYNE, PA. 2002.
  • 5ARIKAN S. Current status of antifungal susceptibility testing methods [J]. Med Mycol, 2007,45(7) : 569-587.
  • 6MARR K A, RUSTAD T R, WHITE T C, et al. The trailing end point phenotype in antifungal susceptibility testing is pH dependent [ J ]. Antimicrob Agents Chemother, 1999, 43(6): 1383-1386.
  • 7PFALLER M A, DIEKEMAN D J, REX J H, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoint [ J ]. J Clln Microbiol, 2006, 44(3) : 819-826.
  • 8MULLER F M, STAUDIGEL A, SALVENMOSER S, et al. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental bavarian vine grapes [ J ]. Antimicrob Agents Chemother, 2007, 57(4) : 3014-3016.
  • 9DENNING D W. Echinocandin antifungal drugs [ J]. Lancet, 2003, 362(9390) : 1142-1151.
  • 10ELLIS D. Amphotericin B: spectrum and resistance [ J]. J Antimicrob Chemother, 2002, 49( 1 ): 7-10.

共引文献285

同被引文献74

  • 1陈翠珠,徐英春,王澎,杨启文,谢秀丽,陈民钧.1557株酵母菌的鉴定及其药敏试验分析[J].中国真菌学杂志,2006,1(3):134-138. 被引量:25
  • 2Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis : biology, epide- miology, pathogenicity and antifungal resistance [ J ]. FEMS Microbiol Rev, 2012, 36(2) : 288-305.
  • 3Rodloff C, Koch D, Schaumann R. Epidemiology and antifungal resistance in invasive candidiasis [ JJ. Eur J Med Res, 2011, 16(4) : 187-195.
  • 4Wang H, Xiao M, Chen SC, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study [J]. J Clin Mierobiol, 2012, 50 (12) : 3952-3959.
  • 5Pfaller MA, Diekema DJ, Ghannoum MA, et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fu- migatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods [J]. J Clin Microbiol, 2009, 47 (10) : 3142-3146.
  • 6Denning DW, Hope WW. Therapy for fungal diseases: opportu- nities and priorities [ J ]. Trends Microbiol, 2010, 18 (5) : 195-204.
  • 7Warrilow AG, Melo N, Martel CM, et at. Expression, purifica- tion, and characterization of Aspergillus fumigates sterol 14-al- pha demethylase (CYP51) isoenzymes A and B [J]. Antimi- crob A gents Chemother, 2010, 54(10) : 4225-4234.
  • 8Nagappan V, Deresinski S. Reviews of anti-infective agents: Posaeonazole: a broad-spectrum triazole antifangal agent [ J ]. Clin Infect Dis, 2007, 45(12) : 1610-1617.
  • 9Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts [ S]. Approved standard-Third edition M27-A3. CLSI, Wayne, PA, 2008.
  • 10Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi[ S]. Approved standard-Second edition M38-A2. CLSI, Wayne, PA, 2008.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部